Clinical Trials in Minneapolis

Showing 13421-13440 of 14,456 trials

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

NCT00291551

This is a limited safety and feasibility study to evaluate the PVSS Introducer and Paracor Ventricular Support System when used to treat patients with heart failure. The implant, which is loaded onto the delivery system, is placed over the epicardial surface of the right and left ventricles. No formal hypothesis testing will be performed; descriptive statistics will be used to summarize patient outcomes. The results of the study will be used to guide the design and sample size estimation of future studies.

Heart Failure, Congestive

Paracor Medical, Inc39 participantsStarted Jan 2005

Birmingham, Alabama, United States • Denver, Colorado, United States • Gainesville, Florida, United States +9 more locations

COMPLETEDPhase 3< 1 mile

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

NCT00013520

The purpose of this study is to compare the effectiveness, safety, and tolerability of 3 anti-HIV combination treatments that do not use protease inhibitors (PIs). The current rule for starting treatment of HIV infection is to combine members from different classes of anti-HIV drugs, such as 2 nucleoside reverse transcriptase inhibitors (NRTIs) and either a PI or a nonnucleoside reverse transcriptase inhibitor (NNRTI). However, these combinations can be complicated and difficult to take, can cause a number of side effects, and may become ineffective. Combinations that are simpler, better tolerated, and more effective are needed. Because PIs can cause long-term side effects and because HIV can become resistant to many of them at the same time, anti-HIV combination treatments that do not use PIs are being tested.

HIV Infections

National Institute of Allergy and Infectious Diseases (NIAID)1,125 participants

Birmingham, Alabama, United States • Los Angeles, California, United States • Los Angeles, California, United States +57 more locations

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Find Trials by Condition in Minneapolis

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Effect of Lapaquistat Acetate Combined With Fenofibrate on Blood Cholesterol Levels

Efficacy of Lapaquistat Acetate and Atorvastatin on Blood Cholesterol Levels in Subjects With Primary Hypercholesterolemia

Efficacy of Lapaquistat Acetate Alone or Combined With Simvastatin in Subjects With Hypercholesterolemia

Efficacy and Safety of Lumiracoxib in Patients With Primary Knee Osteoarthritis(OA)

Efficacy and Safety of Fentanyl Buccal Tablets Compared With Oxycodone for the Management of Break Through Pain

Efficacy of Lapaquistat Acetate Alone or Combined With Rosuvastatin in Subjects With Hypercholesterolemia

Treatment With Interleukin-2 (IL-2) Plus Combination Anti-HIV-Drug Therapy (HAART) for Patients Formerly in ACTG 328

H1N1 Vaccine at Two Dose Levels in HIV Positive Adults

Safety and Tolerability of 28 Days Treatment With Glycopyrronium Bromide (NVA237) (100 or 200 µg Once a Day) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease

Efficacy of ThermoProfen in Patients With Mild to Moderate Pain Associated With Osteoarthritis of the Knee

A Study to Evaluate Safety of Multi-Dose MEDI-545 in Adult Patients With Dermatomyositis or Polymyositis

Study to Assess the Efficacy and Safety of BDP HFA Nasal Aerosol in Patients 12 Years and Older With SAR

A Study of the Safety and Efficacy of CNTO 888 in Combination With SoC (Standard of Care) Chemotherapy in Patients With Solid Tumors

Kaletra Monotherapy in HIV/HCV Co-infected Subjects

Dose Escalation Study With QLT0074 for Benign Prostatic Hyperplasia

Safety Profile, MTD, and PK Profile Studies of ABT-263 When Administered in Combination With Standard and Weekly Regimens of Docetaxel in Subjects With Cancer

Arsenic Trioxide and Imatinib Mesylate in Treating Patients With Chronic Myelogenous Leukemia